{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:02:29Z","timestamp":1773280949637,"version":"3.50.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"DOI":"10.1093\/carcin\/bgi149","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T00:24:16Z","timestamp":1118276656000},"page":"1922-1928","source":"Crossref","is-referenced-by-count":13,"title":["Inhibitory effect of meloxicam, a cyclooxygenase-2 inhibitor, on N -nitrosobis (2-oxopropyl) amine induced biliary carcinogenesis in Syrian hamsters"],"prefix":"10.1093","volume":"26","author":[{"given":"Akihiko","family":"Tsuchida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Itoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kasuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsufumi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,6,8]]},"reference":[{"key":"key\n\t\t\t\t20171012203009_B1","unstructured":"Babbitt,D.D. ( 1969 ) Congenital choledochal cyst: new etiological concept based on anomalous relationships of the common bile duct and pancreatic bulb. Ann. Radiol. , 12 , 231 \u2013240."},{"key":"key\n\t\t\t\t20171012203009_B2","unstructured":"Yokohata,K., Kimura,H., Naritomi,G., Konomi,H., Takeda,T., Ogawa,Y. and Tanaka,M. ( 2000 ) Type classification of anomalous pancreaticobiliary junction by ERCP. J. Hepatobiliary Pancreat. Surg. , 7 , 542 \u2013550."},{"key":"key\n\t\t\t\t20171012203009_B3","doi-asserted-by":"crossref","unstructured":"Funabiki,T., Sugie,K., Matsubara,T., Amano,H. and Ochiai,M. ( 1991 ) Bile acids and biliary carcinoma in pancreaticobiliary maljunction. Keio J. Med. , 40 , 118 \u2013122.","DOI":"10.2302\/kjm.40.118"},{"key":"key\n\t\t\t\t20171012203009_B4","doi-asserted-by":"crossref","unstructured":"Mizuno,M., Kato,T. and Koyama,K. ( 1996 ) An analysis of mutagens in the contents of the biliary tract in pancreaticobiliary maljunction. Surg. Today , 26 , 597 \u2013602.","DOI":"10.1007\/BF00311663"},{"key":"key\n\t\t\t\t20171012203009_B5","doi-asserted-by":"crossref","unstructured":"Matsubara,T., Sakurai,Y., Sasayama,Y., Hori,H., Ochiai,M., Funabiki,T., Matsumoto,K. and Hirono,I. ( 1996 ) K- ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Cancer , 77 , 1752 \u20131757.","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1752::AID-CNCR51>3.0.CO;2-V"},{"key":"key\n\t\t\t\t20171012203009_B6","doi-asserted-by":"crossref","unstructured":"Hanada,K., Tsuchida,A. and Kajiyama,G. ( 1999 ) Cellular kinetics and gene mutations in gallbladder mucosa with an anomalous junction of pancreaticobiliary duct. J. Hepatobiliary Pancreat. Surg. , 6 , 223 \u2013228.","DOI":"10.1007\/s005340050111"},{"key":"key\n\t\t\t\t20171012203009_B7","doi-asserted-by":"crossref","unstructured":"Masuhara,S., Kasuya,K., Aoki,T., Yoshimatsu,A., Tsuchida,A. and Koyanagi,Y. ( 2000 ) Relation between K- ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction. J. Hepatobiliary Pancreat. Surg. , 7 , 198 \u2013205.","DOI":"10.1007\/s005340050176"},{"key":"key\n\t\t\t\t20171012203009_B8","doi-asserted-by":"crossref","unstructured":"Nagai,M., Watanabe,M., Iwase,T., Yamao,K. and Isaji,S. ( 2002 ) Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. World J. Surg. , 26 , 91 \u201398.","DOI":"10.1007\/s00268-001-0187-0"},{"key":"key\n\t\t\t\t20171012203009_B9","doi-asserted-by":"crossref","unstructured":"Tsuchida,A., Nagakawa,Y., Kasuya,K., Itoi,T., Endo,M., Ozawa,T., Aoki,T. and Koyanagi,Y. ( 2003 ) Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction. Oncol. Rep. , 10 , 339 \u2013343.","DOI":"10.3892\/or.10.2.339"},{"key":"key\n\t\t\t\t20171012203009_B10","doi-asserted-by":"crossref","unstructured":"Smith,W.L., Garavito,R.M. and DeWitt,D.L. ( 1996 ) Prostaglandin endoperoxide H syntheses (cyclooxygenase)-1 and -2. J. Biol. Chem. , 271 , 1157 \u20131160.","DOI":"10.1074\/jbc.271.52.33157"},{"key":"key\n\t\t\t\t20171012203009_B11","doi-asserted-by":"crossref","unstructured":"Ohno,R., Yoshinaga,K., Fujita,T., Hasegawa,K., Iseki,H., Tsunozaki,H., Ichikawa,W., Nihei,Z. and Sugihara,K. ( 2001 ) Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric cancer. Cancer , 91 , 1876 \u20131881.","DOI":"10.1002\/1097-0142(20010515)91:10<1876::AID-CNCR1209>3.0.CO;2-H"},{"key":"key\n\t\t\t\t20171012203009_B12","doi-asserted-by":"crossref","unstructured":"Eberhart,C.E., Coffey,R.J., Radika,A., Giardiello,F.M., Ferrenbach,S. and Dubois,R.N. ( 1994 ) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinoma. Gastroenterol. , 107 , 1182 \u20131188.","DOI":"10.1016\/0016-5085(94)90246-1"},{"key":"key\n\t\t\t\t20171012203009_B13","unstructured":"Kudo,T., Narisawa,T. and Abo,S. ( 1980 ) Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. Gann , 71 , 260 \u2013264."},{"key":"key\n\t\t\t\t20171012203009_B14","doi-asserted-by":"crossref","unstructured":"Giovannucci,E., Egan,K.M., Hunter,D.J., Stampfer,M.J., Colditz,G.A., Willett,W.C. and Speizer,F.E. ( 1995 ) Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. , 333 , 609 \u2013614.","DOI":"10.1056\/NEJM199509073331001"},{"key":"key\n\t\t\t\t20171012203009_B15","doi-asserted-by":"crossref","unstructured":"Tsujii,M. and DuBois,R.N. ( 1995 ) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell , 83 , 493 \u2013501.","DOI":"10.1016\/0092-8674(95)90127-2"},{"key":"key\n\t\t\t\t20171012203009_B16","doi-asserted-by":"crossref","unstructured":"Tsujii,M., Kawano,S., Tsuji,S., Sawaoka,H., Hori,M. and DuBois,R.N. ( 1998 ) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell , 93 , 705 \u2013716.","DOI":"10.1016\/S0092-8674(00)81433-6"},{"key":"key\n\t\t\t\t20171012203009_B17","doi-asserted-by":"crossref","unstructured":"Aoki,T., Nagakawa,Y., Tsuchida,A., Kasuya,K., Kitamura,K., Inoue,K., Ozawa,T., Koyanagi,Y and Itoi,T. ( 2002 ) Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors. Oncol. Rep. , 9 , 761 \u2013765.","DOI":"10.3892\/or.9.4.761"},{"key":"key\n\t\t\t\t20171012203009_B18","doi-asserted-by":"crossref","unstructured":"Lala,P.K., Al-Mutter,N. and Orucevic,A. ( 1997 ) Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H\/HEJ mice. Int. J. Cancer , 73 , 371 \u2013380.","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<371::AID-IJC12>3.0.CO;2-G"},{"key":"key\n\t\t\t\t20171012203009_B19","unstructured":"Achiwa,H., Yatabe,Y., Hida,T., Kuroishi,T., Kozaki,K., Nakamura,S., Ogawa,M., Sugiura,T., Mitsudomi,T. and Takahashi,T. ( 1999 ) Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin. Cancer Res. , 5 , 1001 \u20131005."},{"key":"key\n\t\t\t\t20171012203009_B20","doi-asserted-by":"crossref","unstructured":"Tajima,Y., Eto,T., Tsunoda,T., Tomioka,T., Inoue,K., Fukahori,T. and Kanematsu,T. ( 1994 ) Induction of extrahepatic biliary carcinoma by N -nitrosobis (2-oxopropyl) amine in hamsters given cholecystoduodenostomy with dissection of the common duct. Jpn. J. Cancer Res. , 85 , 780 \u2013788.","DOI":"10.1111\/j.1349-7006.1994.tb02948.x"},{"key":"key\n\t\t\t\t20171012203009_B21","doi-asserted-by":"crossref","unstructured":"Furukawa,F., Nishikawa,A., Imaida,K., Mitsui,M., Enami,T., Hayashi,Y. and Takahashi,M. ( 1992 ) Inhibitory effects of crude soybean trypsin inhibitor on pancreatic ductal carcinogenesis in hamsters after initiation with N -nitrosobis (2-oxopropyl) amine. Carcinogenesis , 13 , 2133 \u20132135.","DOI":"10.1093\/carcin\/13.11.2133"},{"key":"key\n\t\t\t\t20171012203009_B22","doi-asserted-by":"crossref","unstructured":"Furukawa,F., Nishikawa,A., Imazawa,T., Yoshimuta,H., Sato,M., Aze,Y. and Takahashi,M. ( 1994 ) Blocking effects of synthetic trypsin inhibitor (camostat) on pancreatic carcinogenesis in hamsters initiated with N -nitrosobis (2-oxopropyl) amine. Pancreas , 9 , 78 \u201382.","DOI":"10.1097\/00006676-199401000-00012"},{"key":"key\n\t\t\t\t20171012203009_B23","doi-asserted-by":"crossref","unstructured":"Clapper,M.L., Wood,M., Leahy,K., Lang,D., Miknyoczki,S. and Ruggeri,B.A. ( 1995 ) Chemopreventive activity of Oltipraz against N -nitrosobis (2-oxopropyl) amine (BOP)-induced ductal pancreatic carcinoma development and effects on survival of Syrian golden hamsters. Carcinogenesis , 16 , 2159 \u20132165.","DOI":"10.1093\/carcin\/16.9.2159"},{"key":"key\n\t\t\t\t20171012203009_B24","unstructured":"Nakamura,H., Nishikawa,A., Furukawa,F., Kasahara,K., Miyauchi,M., Son,H.Y. and Hirose,M. ( 2000 ) Inhibitory effects of protocatechuic acid on the post-initiation phase of hamster pancreatic carcinogenesis induced by N -nitrosobis (2-oxopropyl) amine. Anticancer Res. , 20 , 3423 \u20133427."},{"key":"key\n\t\t\t\t20171012203009_B25","doi-asserted-by":"crossref","unstructured":"Furukawa,F., Nishikawa,A., Lee,I.S., Son,H.Y., Nakamura,H., Miyauchi,M., Takahashi,M. and Hirose,M. ( 2000 ) Inhibition by methionine of pancreatic carcinogenesis in hamsters after initiation with N -nitrosobis (2-oxopropyl) amine. Cancer Lett. , 152 , 162 \u2013167.","DOI":"10.1016\/S0304-3835(99)00448-6"},{"key":"key\n\t\t\t\t20171012203009_B26","doi-asserted-by":"crossref","unstructured":"Furukawa,F., Nishikawa,A., Lee,I.S., Kanki,K., Umemura,T., Okazaki,K., Kawamori,T., Wakabayashi,K. and Hirose,M. ( 2003 ) A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N -nitrosobis (2-oxopropyl) amine-induced pancreatic carcinogenesis in hamsters. Int. J. Cancer , 104 , 269 \u2013273.","DOI":"10.1002\/ijc.10965"},{"key":"key\n\t\t\t\t20171012203009_B27","doi-asserted-by":"crossref","unstructured":"Ogura,Y., Matsuda,S., Ito,M., Niimi,R., Sumimoto,M. and Kawarada,Y. ( 2000 ) Chemoprevention of biliary carcinogenesis in Syrian hamsters by the novel carboxamide derivative IS-741 after initiation with N -nitrosobis (2-oxopropyl) amine (BOP). Carcinogenesis , 21 , 1469 \u20131475.","DOI":"10.1093\/carcin\/21.5.469"},{"key":"key\n\t\t\t\t20171012203009_B28","doi-asserted-by":"crossref","unstructured":"Miyauchi,M., Nishikawa,A., Furukawa,F., Nakamura,H., Son,H.Y., Murakami,A., Koshimizu,K., Ohigashi,H. and Hirose,M. ( 2000 ) Inhibitory effects of 1\u2032-acetoxychavicol acetate on N -nitrosobis (2-oxopropyl) amine-induced initiation of cholangiocarcinogenesis in Syrian hamsters. Jpn. J. Cancer Res. , 91 , 477 \u2013481.","DOI":"10.1111\/j.1349-7006.2000.tb00970.x"},{"key":"key\n\t\t\t\t20171012203009_B29","doi-asserted-by":"crossref","unstructured":"Ogura,Y., Matsuda,S., Itho,M., Sasaki,H., Tanigawa,K. and Shimomura,M. ( 2002 ) Inhibitory effect of loxiglumide (CR1505), a cholecystokinin receptor antagonist, on N -nitrosobis (2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters. World J. Surg. , 26 , 359 \u2013365.","DOI":"10.1007\/s00268-001-0233-y"},{"key":"key\n\t\t\t\t20171012203009_B30","unstructured":"Albores-Saavedra,J., Henson,D.E. and Klimstra,D.S. ( 1999 ) Tumors of the Gallbladder and Extrahepatic Bile Ducts . Atlas of Tumor Pathology. AFIP, Washington, DC, pp. 206\u2013214."},{"key":"key\n\t\t\t\t20171012203009_B31","unstructured":"Hamilton,S.R. and Analtonen,L.A. (eds) ( 2000 ) Pathology and Genetics of Tumors of the Digestive System . Tumors of the gallbladder and extrahepatic bile ducts. World Health Organization. IARC, Lyon."},{"key":"key\n\t\t\t\t20171012203009_B32","doi-asserted-by":"crossref","unstructured":"Tsuchida,A., Itoi,T., Aoki,T. and Koyanagi,Y. ( 2003 ) Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review). Oncol. Rep. , 10 , 1693 \u20131699.","DOI":"10.3892\/or.10.6.1693"},{"key":"key\n\t\t\t\t20171012203009_B33","doi-asserted-by":"crossref","unstructured":"Reveille,R.M., VanStiegmann,G. and Everson,G.T. ( 1990 ) Increased secondary bile acids in choledochal cyst; possible role in biliary metaplasia and carcinoma. Gastroenterol. , 99 , 525 \u2013527.","DOI":"10.1016\/0016-5085(90)91036-6"},{"key":"key\n\t\t\t\t20171012203009_B34","doi-asserted-by":"crossref","unstructured":"Tashiro,S., Imaizumi,T., Ohkawa,H., Okada,A., Katoh,T., Kawarada,Y., Shimada,H., Takamatsu,H., Miyake,H. and Todani,T. ( 2002 ) Overall report on the registration study of the Japanese Study Group on Pancreaticobiliary Maljunction for the past 10 years. In Koyanagi,Y. and Aoki,T. (eds), Pancreaticobiliary Maljunction . Igaku Tosho, Tokyo, pp. 401\u2013410.","DOI":"10.1007\/s00534-002-0741-7"},{"key":"key\n\t\t\t\t20171012203009_B35","unstructured":"Oshima,M., Murai,N., Kargman,S., Arguello,M., Luk,P., Kwong,E., Takeo,M.M. and Evans,J.F. ( 2001 ) Chemoprevention of intestinal polyposis in the Apc\u0394716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res. , 61 , 1733 \u20131740."},{"key":"key\n\t\t\t\t20171012203009_B36","doi-asserted-by":"crossref","unstructured":"Fujita,M., Fukui,H., Kusaka,T., Morita,K., Fujii,S., Ueda,Y., Chiba,T., Sakamoto,C., Kawamata,H. and Fujimori,T. ( 2000 ) Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas. J. Gastroenterol. Hepatol. , 15 , 1277 \u20131281.","DOI":"10.1046\/j.1440-1746.2000.02399.x"},{"key":"key\n\t\t\t\t20171012203009_B37","doi-asserted-by":"crossref","unstructured":"Pai,R., Soreghan,B., Szabo,I.L., Pavelka,M., Baatat,D. and Tarnawski,A.S. ( 2002 ) Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. , 8 , 289 \u2013293.","DOI":"10.1038\/nm0302-289"},{"key":"key\n\t\t\t\t20171012203009_B38","doi-asserted-by":"crossref","unstructured":"Buchanan,F.G., Wang,D., Bargiacchi,F. and DuBois,R.N. ( 2003 ) Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J. Biol. Chem. , 24 , 35451 \u201335457.","DOI":"10.1074\/jbc.M302474200"},{"key":"key\n\t\t\t\t20171012203009_B39","doi-asserted-by":"crossref","unstructured":"Yasumaru,M., Tsuji,S., Tsujii,M. et al . ( 2003 ) Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Cancer Res. , 63 , 6726 \u20136734.","DOI":"10.1016\/S0016-5085(03)80280-9"},{"key":"key\n\t\t\t\t20171012203009_B40","doi-asserted-by":"crossref","unstructured":"Husain,S.S., Szabo,I.L., Pai,R., Soreghan,B., Jones,M.K. and Tarnawski,A.S. ( 2001 ) MAPK (ERK2) kinase\u2014a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth. Life Sci. , 69 , 3045 \u20133054.","DOI":"10.1016\/S0024-3205(01)01411-4"},{"key":"key\n\t\t\t\t20171012203009_B41","doi-asserted-by":"crossref","unstructured":"Takahashi,M., Ota,S., Hata,Y., Mikami,Y., Azuma,N., Nakamura,T., Terano,A. and Omata,M. ( 1996 ) Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J. Clin. Invest. , 98 , 2604 \u20132611.","DOI":"10.1172\/JCI119080"},{"key":"key\n\t\t\t\t20171012203009_B42","doi-asserted-by":"crossref","unstructured":"Han,C., Leng,J.M., Demetris,A.J. and Wu,T. ( 2004 ) Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cycloxygenase-2-independent mechanism in celecoxib-mediated induction of p21 waf1\/cip1 and p27 kip1 and cell cycle arrest. Cancer Res. , 64 , 1369 \u20131376.","DOI":"10.1158\/0008-5472.CAN-03-1086"},{"key":"key\n\t\t\t\t20171012203009_B43","doi-asserted-by":"crossref","unstructured":"Kitajima,T., Tajima,Y., Matsuzaki,S., Kuroki,T., Fukuda,K. and Kanematsu,T. ( 2003 ) Acceleration of spontaneous biliary carcinogenesis in hamsters by bilioenterostomy. Carcinogenesis , 24 , 133 \u2013137.","DOI":"10.1093\/carcin\/24.1.133"},{"key":"key\n\t\t\t\t20171012203009_B44","doi-asserted-by":"crossref","unstructured":"Wu,G.S., Zou,S.Q., Liu,Z.R., Tang,Z.H. and Wang,J.H. ( 2003 ) Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines. World J. Gastroenterol. , 9 , 1302 \u20131306.","DOI":"10.3748\/wjg.v9.i6.1302"},{"key":"key\n\t\t\t\t20171012203009_B45","doi-asserted-by":"crossref","unstructured":"Nzeako,U.C., Guicciardi,M.E., Yoon,J.H., Bronk,S.F. and Gores,G.J. ( 2003 ) COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells. Hepatology , 35 , 552 \u2013559.","DOI":"10.1053\/jhep.2002.31774"},{"key":"key\n\t\t\t\t20171012203009_B46","doi-asserted-by":"crossref","unstructured":"Jendrossek,V., Handrick,R. and Belka,C. ( 2003 ) Celecoxib activates a novel mitochondrial apoptosis signaling pathway. FASEB , 17 , 1547 \u20131549.","DOI":"10.1096\/fj.02-0947fje"},{"key":"key\n\t\t\t\t20171012203009_B47","doi-asserted-by":"crossref","unstructured":"Blain,H., Boileau,C., Lapicque,F., Nedelec,E., Loeuille,D., Guilaume,C., Gaucher,A., Jeandel,C., Netter,P. and Jouzeau,J.Y. ( 2002 ) Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. Br. J. Clin. Pharmacol. , 53 , 255 \u2013265.","DOI":"10.1046\/j.0306-5251.2001.01533.x"},{"key":"key\n\t\t\t\t20171012203009_B48","unstructured":"Panara,M.R., Renda,G., Sciulli,M.G., Santini,G., Di Giamberardino,M., Rotondo,M.T., Tacconelli,S., Seta,F., Patrono,C. and Patrignani,P. ( 1999 ) Dose\u2013dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. J. Pharmacol. Exp. Ther. , 290 , 276 \u2013280."},{"key":"key\n\t\t\t\t20171012203009_B49","doi-asserted-by":"crossref","unstructured":"Gierse,J.K., Koboldt,C.M., Walker,M.C., Seibert,K. and Isakson,P.C. ( 1999 ) Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem. J. , 339 , 607 \u2013614.","DOI":"10.1042\/bj3390607"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/26\/11\/1922\/7512257\/bgi149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T15:42:40Z","timestamp":1586274160000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/carcin\/article\/26\/11\/1922\/2476031\/Inhibitory-effect-of-meloxicam-a-cyclooxygenase2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,8]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,6,8]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgi149","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,11]]},"published":{"date-parts":[[2005,6,8]]}}}